The Genomic Grade Index (GGI) – a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

C Desmedt, A Giobbie-Hurder + Show 8 more

https://doi.org/10.1016/s1359-6349(08)70797-3

Copy DOI

Publication Date: Apr 1, 2008

Abstract

The Genomic Grade Index (GGI) – a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author